Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+०.२८%
१,०८५.८१
+३.०१
+०.२८%
—१,०८२.८०१,०७९.३११,०९०.१८१,०७९.३१——
SIXC
Communications
SIXC
Communications
SIXC
+०.६५%
६०७.६९
+३.९२
+०.६५%
—६०३.७७६०३.७७६११.६५६०२.०९——
SIXE
Energy
SIXE
Energy
SIXE
-१.५५%
१,१९२.३८
-१८.८१
-१.५५%
—१,२११.१९१,२०३.०५१,२०३.४८१,१८२.७२——
SIXI
Industrials
SIXI
Industrials
SIXI
+०.०२%
१,७५६.३९
+०.४०
+०.०२%
—१,७५५.९९१,७५९.०६१,७६१.७४१,७४७.२३——
SIXM
Financials
SIXM
Financials
SIXM
-०.८२%
६३३.२७
-५.२४
-०.८२%
—६३८.५१६३७.९३६४०.१०६३१.८९——
SIXR
Staples
SIXR
Staples
SIXR
+१.१२%
८५२.४२
+९.४६
+१.१२%
—८४२.९६८४३.५४८५८.४४८४३.५४——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.२२%
२१८.७९
-०.४९
-०.२२%
—२१९.२८२१९.२८२२०.५८२१८.६४——
SIXT
Technology
SIXT
Technology
SIXT
-०.४५%
३,७११.६९
-१६.६६
-०.४५%
—३,७२८.३५३,७४५.०६३,७४५.०६३,६७५.०२——
SIXU
Utilities
SIXU
Utilities
SIXU
-०.४८%
९११.०५
-४.४३
-०.४८%
—९१५.४८९१४.४९९१५.८४९०७.९०——
SIXV
Health care
SIXV
Health care
SIXV
+०.२२%
१,५००.६६
+३.३०
+०.२२%
—१,४९७.३६१,५००.६५१,५१४.७०१,४९५.८९——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+१.७३%
२,४५४.९६
+४१.७९
+१.७३%
—२,४१३.१७२,४३१.६९२,४६३.५२२,४३१.६९——
GMAB:NASDAQ
Genmab A/S - ADR
US$ २६.७१
-०.६७%
(-०.१८) 1D
US$ २६.७१
०.००% (०.००)
After hours
Closed: मे २७, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GMAB...
Open
US$ २६.७९
High
US$ २६.९७
Low
US$ २६.६०
Mkt. cap
१६.७४ अरब
Avg. vol.
२०.२४ लाख
Volume
७.९१ लाख
P/E ratio
२०.२३
52-wk high
US$ ३५.४३
52-wk low
US$ २०.२२
EPS
US$ १.३२
Beta
०.८६
Shares outstanding
६२.३५ करोड
No. of employees
३ हजार
News stories
From sources across the web
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees३.०९ हजार
Founded१९९९
Headquarters-
Sector-
Websitegenmab.com
Last report
२०२६ मे ७
Fiscal period
Q1 2026
EPS / Est. (DKK)
- / DKK ८.२३
Revenue / Est. (DKK)
५.६९ अरब / ५.६५ अरब
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
२०२३ डिसेम्बर
२०२४ मार्च
२०२४ जुन
२०२४ सेप्टेम्बर
Revenue
४.६८ अरब
४.१४ अरब
५.४० अरब
५.५४ अरब
Cost of goods sold
-
-
-
२७.३० करोड
Cost of revenue
-
-
-
२७.३० करोड
Research and development expenses
-
-
-
२.२८ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
८६.५० करोड
Operating expense
-
-
-
३.१५ अरब
Total operating expenses
-
-
-
३.४२ अरब
Operating income
-
-
-
२.१२ अरब
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
१.७२ अरब
EBT excluding unusual items
-
-
-
१.५९ अरब
Income tax expense
-
-
-
४५.३० करोड
Effective tax rate
-
-
-
२६.३५%
Other operating expenses
-
-
-
-
Net income
-
-
-
१.२७ अरब
Net profit margin
-
-
-
२२.८५%
Earnings per share
९.६७
-
-
१९.८१
Interest and investment income
-
-
-
१६.२० करोड
Interest expense
-
-
-
-१.८० करोड
Net interest expenses
-
-
-
१४.४० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
२.२० अरब
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer